PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600–Mutated Melanoma release_rev_f2281b23-7333-40b3-8041-6618cd735fa7

by Margaret K. Callahan, Paul B. Chapman

Published in Journal of Clinical Oncology by American Society of Clinical Oncology (ASCO).

2022  

Type  article-journal
Stage   published
Date   2022-01-14
Language   en ?
Journal Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0732-183X
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Revision

This is a specific, static metadata record, not necessarily linked to any current entity in the catalog.

Catalog Record
Revision: f2281b23-7333-40b3-8041-6618cd735fa7
API URL: JSON